# Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

> **NCT00639106** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 70 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Alloderm, Questionnaires
- **PROCEDURE:** Without ALLODERM, Questionnaires

## Key facts

- **NCT ID:** NCT00639106
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-10-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639106, "Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00639106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
